Envision Health

“The Envision team lives and breathes healthcare, and these individuals will augment and enhance our unique delivery of healthcare marketing and PR in this highly competitive marketplace, as we help companies who are making a real difference in healthcare.”– Kelley Smith

BLOOMFIELD HILLS, Mich. (PRWEB)
December 02, 2021

Award-winning healthcare marketing and public relations firm, Envision Health, is pleased to announce the addition of four new respected senior-level leaders.

“Our organizational mission is simple; to partner with our clients to help them achieve their greatest success balanced with an incredibly positive and productive culture. We’re seeking individuals who are aligned with our core values, and have the ability to collaborate from the heart, remain present in the moment and continually pursue excellence,” said Tim Busche, MBA, President and CEO. “We’re very proud to welcome each of these highly talented leaders who are aligned with our greater purpose and these values and ready to simply make a profound difference.”

Joining Envision Health are:

Alex Sargeant as Creative Director / Account Lead — Alex is an award-winning copywriter and marketing communications professional with a track record for developing innovative creative concepts and engaging digital content to build awareness, generate inquiries, drive demand and inspire action. Alex was previously Director of Marketing and Public Relations at Regional Medical Center in Orangeburg, SC and Senior Writer at Sonoco. He holds a BA from the University of South Carolina.

Jacquie Nelson as Marketing and Public Relations Manager — Jacquie has spent the last 25 years across all communications platforms including B2B, B2C, non-profit and higher education both on the agency and client side. She is a skilled developer of strategic communications that align cutting-edge creative direction with comprehensive communication plans that drive results. She earned an MA, Strategic Communications from Bowling Green State University.

Alyssa Meier as Director of CRM & Marketing Automation — Alyssa has led marketing and creative teams in healthcare, transportation, tribal government, and sports technology. In 2016 she earned a SalesForce Pardot Certification, implemented the platform, and created user-specific journeys to cater to the healthcare industry. She since has immersed herself in both SalesForce Marketing Cloud and Marketo and has been a key driver in open rate increases, marketable audience cleansing, and lead generation efforts. She holds a Bachelor of Science from Minnesota State University, Mankato in Journalism, Marketing, and Graphic Design.

Lauri Lemire as Creative Director — Lauri is a seasoned senior art director and creative team manager with experience in multiple industries, including technology, automotive and sports. She also served as Senior Art director at NEXTEP Systems as well as a graphic designer for Ford Motor Company. She holds a BFA from the University of Dayton.

In 2020, Envision Health was recognized as one of the awardees for the Michigan 50 Companies to Watch award, presented by Michigan Celebrates Small Business. The organization has grown by 400% in the last four years and it continues to expand its staff, creative and operational effectiveness and has continued to expand its base clients across the globe.

“Today’s increasingly complex and confusing healthcare environment requires in-depth know-how,” said Kelley Smith, RN, MPH, Chief Clinical Officer and co-founder of Envision Health. “The Envision team lives and breathes healthcare, and these individuals will augment and enhance our unique delivery of healthcare marketing and PR in this highly competitive marketplace, as we help companies who are making a real difference in healthcare.”

For more information, please contact Susan Thwing at susan@envhs.com.

About Envision Health

Envision Health is an award-winning marketing, public relations and consulting partner for businesses in healthcare and healthcare technology. Founded by two industry experts with 50+ years of combined healthcare experience, we believe the convergence of clinical insight and marketing and PR expertise is the key to transforming healthcare communications. We are “clinically informed” — this means that everything we do is backed by deep healthcare expertise and first-hand knowledge of the landscape our customers operate in. Our services encompass everything from marketing strategies and tactics, to company rebrands, to media relations. Envision’s clinical and marketing experts ensure every marketing and public relations deliverable is strategically aligned, clinically informed and creatively inspired.

Share article on social media or email:

IPVideo Corporation HALO Smart Sensor

BAY SHORE, N.Y. (PRWEB)
December 02, 2021

IPVideo Corporation’s HALO Smart Sensor 2C, the worldwide leader for vape and vape with THC detection, has won an ‘ASTORS’ Homeland Security Award from American Security Today in two categories: Best Back to Work Monitoring Solution and Best Sound & Chemical Incident Detection.

The HALO Smart Sensor’s all-in-one capabilities and new 2C hardware unit with calibrated sensors have been recognized for helping organizations get back to work during the pandemic. HALO 2C provides both a real-time air quality and health index, and sends alerts when either index falls into danger zones.

“We have been hearing from building occupants worldwide to provide real-time health and air quality readings of their facilities,” said IPVideo Corporation’s President, David Antar. “With HALO 2C and the real-time health and safety index, facilities now have constant monitoring, immediate alerts, reporting validation and can provide peace of mind to their occupants.”

HALO 2C allows its users to capture comprehensive building awareness with a single device. Used for health and safety, HALO 2C is a vape detector, an air quality monitor, and a complete security device for privacy areas where cameras or microphones aren’t ideal. HALO provides: Building Health Monitoring, Indoor Air Quality Monitoring, Vape Detection, THC Detection, Gunshot Detection, Emergency Key Word Alerting, Audible Alerting, Light/Occupancy Alerting, Chemical Alerting, VOC Alerting, Tamper Alerting as well as Temperature, Humidity and Pressure Alerting.

The Annual ‘ASTORS’ Awards, now in its sixth year, is the preeminent U.S. Homeland Security Awards Program, highlighting the most cutting-edge and forward-thinking security solutions coming onto the market today.

“’ASTORS’ nominations are evaluated on their technical innovation, interoperability, specific impact within the category, the overall impact to the industry, relatability to other industry technologies, and application feasibility outside of the industry,” said AST’s Publisher, Michael J. Madsen.

Capture real-time comprehensive building safety and health awareness with the all-in-one HALO Smart Sensor 2C and the HALO Cloud Health Index.

HALO IOT Smart Sensor is Patent Protected and is proudly manufactured in the U.S.A.

For further information regarding IPVideo’s award-winning HALO Smart Sensor 2C visit http://www.ipvideocorp.com/halo/ or call 631-969-2601.

PR Contact:

Rick Cadiz

Vice President Sales & Marketing

IP Video Corporation

631.675.2213

rcadiz@ipvideocorp.com

About IPVideo Corporation:

An industry pioneer since its introduction of one of the first network-based surveillance recording solutions in 1996, IPVideo Corporation is now at the forefront of developing unique, innovative solutions that harness the power of IP video technology. Today, the company’s systems are trusted by Fortune 500 companies, government agencies and municipalities, utilities, healthcare facilities, school districts, and leading universities to mitigate risk while protecting people and properties. A commitment to an open-standards philosophy and delivering best-in-class performance and value underlies all offerings―from physical security solutions that bridge to the Internet of Things, to purpose-built HD audio/video recording solutions for education, law enforcement, healthcare, and beyond. The company’s worldwide client base is served by a network of certified distributors, dealers, and system integrators, who benefit from ongoing corporate support and training. IPVideo Corporation is headquartered in Bay Shore, NY. For more information, visit http://www.ipvideocorp.com.

About American Security Today:

American Security Today (AST), the ‘New Face in Homeland Security™’, is the premier digital media platform in the U.S. Homeland Security and Public Safety Industry, focused on breaking news and in-depth coverage of the newest initiatives and hottest technologies in physical & IT security on the market today.

AST highlights the most cutting-edge and forward-thinking security solutions across a wide variety of media products delivered daily, weekly and monthly to over 75,000 qualified government and security industry readers, essential to meeting today’s growing security challenges to ‘Secure our Nation, One City at a Time™’.

To learn more visit http://www.americansecuritytoday.com, or contact AST by email at mmadsen@americansecuritytoday.com or phone 646-450-6027.

Share article on social media or email:

Alpha Paw’s Genius Litter with health indicator

AUSTIN, Texas (PRWEB)
December 02, 2021

Genius Litter received the top accolade for cat litter from the Pet Business Industry Recognition Awards, which celebrates the most innovative products and companies in the pet care category. Genius Litter was one of 110 top products and companies awarded this year in the pet industry. Recently launched by pet wellness company Alpha Paw, Genius Litter is making it easy for pet parents to keep an eye on their cat’s health. The built-in health indication changes colors and makes it easy for owners to identify irregular values in their cat’s urine such as blood, alkaline, bilirubin, or abnormal PH levels with just one glance.

Genius Litter is a more cost-effective alternative to other litters on the market and the odor-trapping crystals provide a safer, cleaner and clump free experience for your pet all month long while reducing the carbon footprint and minimizing product waste. When you’re ready to change out the litter, cat parents can throw Genius Litter in their garden without fear of polluting their environment. Taking it a step further, for each bag sold, CEO and Founder Ramon van Meer is donating thirty meals to cats in shelters throughout the country.

“Our mission is to create products that prioritize pet wellness while simultaneously minimizing waste and creating a more pet-friendly planet,” says Alpha Paw CEO Ramon van Meer. “Using Genius Litter gives our customers an advantage when it comes to monitoring their cat’s health so they can take the necessary measures before it’s too late.”

With products ranging from customized pet food, to dog ramps and supplements, Alpha Paw is making it easier than ever to address any wellness need that your beloved pet might have.

For every product purchased, Alpha Paw donates meals to shelter dogs and cats across the country. To date, they have donated over 500,000 meals and counting! The company also launched its own charitable foundation, The Alpha Paw Foundation, which partners with local and national non-profits and shelters and hosts donation drives and adoption events, aimed at helping as many rescue animals as possible find loving homes. For more information, visit alphapaw.com.

###

About Alpha Paw:

Alpha Paw creates high-quality breed-specific pet food and wellness products designed for the unique health needs of your pet. The catalog includes our latest health indicator Genius Litter, dog supplements, and the #1 Vet Recommended Dog Ramp: PawRamp. As a company of pet parents, Alpha Paw knows that every breed has a different need. That’s why we work together with a team of experts to develop products that cater to your pets’ unique needs. Alpha Paw adheres to the highest standards and carefully curates its resources and wellness products to give your pet a happier and healthier life. Making them one-stop-shop pet parents can trust. Now sold on our website, AlphaPaw.com.

Share article on social media or email:

“We continue to expand our security program including adding HIPAA compliance for managing healthcare information. Each year brings new security issues and requirements, and the 360 Advanced team has been invaluable in helping us with our Information security initiatives.”

NILES, Ill. (PRWEB)
December 02, 2021

Johnson & Quin, a leading direct mail services provider for over 40 years, today announced the successful completion of their System and Organizational Controls (SOC) 2® Type 2 examination and HIPAA security compliance assessment. These achievements reflect their organization’s commitment to data security and privacy, while giving them a competitive edge in their industry.

Johnson & Quin offers the latest in direct mail production, as well as data services, personalization technologies, quality processes and certified data security practices. The innovation, flexibility, and solid financial credentials that propelled us throughout our history remain at the core of the way we work today.

“Information security continues to be a key attribute of our company,” explained Manish Haria, VP of IT and CISO at Johnson & Quin. “SOC 2 is a requirement for more and more organizations to handle their marketing data and information. We continue to expand our security program including adding HIPAA compliance for managing healthcare information. Each year brings new security issues and requirements, and the 360 Advanced team has been invaluable in helping us with our Information security initiatives.”

With the completion of the SOC 2 Type 2 examination and HIPAA assessment as part of a single streamlined engagement, Johnson & Quin has created a cohesive security posture across all its operations, allowing the company to make more informed decisions about how best to protect their clients and their customers’ information. The efforts were completed by the professional and independent third-party audit firm, 360 Advanced, Inc.

About Johnson & Quin

Throughout the years, Johnson & Quin has prospered by deploying the latest technologies and adapting to the changing marketplace. We led the introduction of laser printing to the Midwest in 1979, which soon transformed Johnson & Quin into a full-service direct mail production company. In 2014 the latest technology in printing, a high-speed color inkjet printing system, was installed. Color inkjet combines and prints all color images, copy and personalized variables in one production process. Benefits include reduced postage and production costs, unlimited versioning, elimination of preprinted forms and shorter schedules. We offer high-speed, high-volume direct mail production, which is supported by the latest technologies in data services, personalization, quality processes and certified data security practices. For over 145 years the company has been built on innovation, flexibility, and solid financial credentials that remain at the core of our business along with a focus on supporting our clients and their marketing programs. For more information, please visit http://www.j-quin.com.

For Johnson & Quin inquiries, please contact:

Kay Wilt, Director of Marketing

kwilt@j-quin.com

About 360 Advanced

360 Advanced is “Making Better Businesses” through their Cybersecurity and Compliance offerings. Services provided include SOC 1, SOC 2, SOC 3, SOC for Cybersecurity, SOC for Supply Chain, CSA STAR, HIPAA/HITECH, ISO 27001, PCI-DSS, HITRUST CSF, Microsoft SSPA Attestation, Penetration Testing, GDPR, CCPA, CMMC and more. In certain states, 360 Advanced may operate under the name of Hiestand, Brand, Loughran, P.A. to meet State Board requirements for CPA firms. To learn more about 360 Advanced, visit http://www.360advanced.com.

For more information on compliance solutions, contact Jim Brennan at jbrennan@360advanced.com.

Media Contact:

Eric Seward

eseward@360advanced.com

Share article on social media or email:

“This data demonstrates that liquid PD-L1 RNA expression is as clinically beneficial as tissue PD-L1,” Dr. Paul Walker, Chief Medical Officer of CIRCULOGENE said. “Plasma PD-L1 has significant clinical utility guiding immunotherapy treatment.”

BIRMINGHAM, Ala. and PENSACOLA, Fla. (PRWEB)
December 02, 2021

CIRCULOGENE, an innovative medical technology company transforming precision medicine through the rapid delivery of actionable results, today announced plasma PD-L1 outcomes data presented at the American Society for Radiation Oncology (ASTRO) Multidisciplinary Thoracic Cancers Symposium being held December 2-4 at the Fairmont Scottsdale Princess in Scottsdale, Arizona.

Conclusions of Data Presented:

 Plasma cell free PD-L1 RNA (cfRNA) expression was predictive of survival benefit of immunotherapy treatment over chemotherapy in a real-world population of advanced non-small cell lung cancer (NSCLC) patients.

 The 3-year landmark outcome study of 30% parallels tissue PD-L1 predictive clinical trial outcomes.

“This data demonstrates that liquid PD-L1 RNA expression is as clinically beneficial as tissue PD-L1,” Dr. Paul Walker, Chief Medical Officer of CIRCULOGENE said. “Plasma PD-L1 has significant clinical utility guiding immunotherapy treatment.”

“CIRCULOGENE offers the only tumor molecular test including liquid/plasma PD-L1 that has been demonstrated to be predictive of immunotherapy survival benefit,” said Mike Mullen, President and CEO of CIRCULOGENE. “The presence of PD-L1 is important to oncologists for making effective patient treatment decisions such as immunotherapy versus chemotherapy. Getting the right treatment to the right patient leads to better outcomes.”

Dr. Walker’s pre-recorded review of the study and clinical outcome can be viewed on the CIRCULOGENE YouTube Channel.

About CIRCULOGENE

CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers, allowing physicians to match patient results with specific therapies in just one week. The company has developed proprietary enrichment technology to minimize genetic data loss, so their sequencing and qPCR methods can provide a full genomic load analysis which helps clinicians select targeted therapies, monitor efficacy, and assess recurrence for cancer patients. Applying their proprietary liquid biopsy innovation for cfDNA and cfRNA, including PD-L1 and MSI detection, CIRCULOGENE can detect circulating germline and somatic mutations and RNA fusions.

CIRCULOGENE is a Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified laboratory and a Verified Vendor for the federal System for Award Management. For more information, visit our website at circulogene.com, connect with us on LinkedIn, Facebook, and Twitter, email info@circulogene.com, or call us at 855-614-7083. Clinicians interested in ordering tests may also visit our contact page at circulogene.com/contact.

Share article on social media or email:

As these combined cuts are phased-in over the next four years, they will do lasting damage to specialty providers under the PFS, accelerate health system consolidation, and further undermine the Part A Trust Fund as patients are forced to move to higher cost sites-of-service.

WASHINGTON (PRWEB)
December 02, 2021

On November 19, the Centers for Medicare & Medicaid Services (CMS) released the CY22 Physician Fee Schedule (PFS) final rule, which contains huge 20 percent cuts to specialty providers as a result of the so-called “clinical labor” update. These cuts follow on the heels of the CY21 PFS final rule which included an across the board cut to the conversion factor of 10 percent, a cut so large that Congress was obliged to step in and block the cuts as part of H.R. 133, the Consolidated Appropriations Act of 2021. As these combined cuts are phased-in over the next four years, they will do lasting damage to specialty providers under the PFS, accelerate health system consolidation, and further undermine the Part A Trust Fund as patients are forced to move to higher cost sites-of-service.

These reductions also disproportionately impact minority populations as exemplified below:

->Venous Ulcer / Endovenous radiofrequency ablation — Black patients present with more advanced venous insufficiency than white patients: Key Code (36475) cut by 23%

-> ESRD / Dialysis Vascular Access — Black and Latino patients start dialysis with a fistula less frequently despite being younger: Key Code (36902) cut by 18%

->Cancer / Radiation oncology — Black men are 111 percent more likely to die of prostate cancer; Black women are 39 percent more likely to die of breast cancer: Key Code (G6015) cut by 15%

->Peripheral Artery Disease/ Revascularization — Black Medicare beneficiaries are three times more likely to receive an amputation; Latino are twice as likely: Key Codes (37225-37221) cut by 22%

->Fibroid / Uterine Fibroid Embolization — Uterine fibroids are diagnosed roughly three times more frequently in Black women: Key Code (37243) cut by 21%

*Note: In the 2022 PFS Final Rule, CMS phases-in these cuts over 4 years. Cuts in this table are estimates based on the 2022 PFS Proposed Rule as CMS did not publish the effects of the cuts over the 4-year period.

Ongoing cuts to office-based specialists under the PFS also are weakening our healthcare system’s ability to deal with the ongoing COVID-19 pandemic. A key lesson learned since the start of the pandemic is that it is critical that hospitals be able to focus on our sickest pandemic patients. Yet many other patients dealing with cancer, end-stage renal disease, critical-limb ischemia, and other post-acute issues cannot wait for the cancer care, dialysis vascular access repair, limb salvage, imaging, physical therapy, etc. that is critical to keeping them alive or out of the hospital. Office-based care under the PFS provides a critical site-of-service outside of the hospital to deal with non-COVID cases so hospitals can focus on a resurging pandemic. Conversely, ongoing cuts to PFS providers threaten the resilience of our health care system to deal with this or any other pandemic. It is clear that any benefits of proceeding with the clinical labor policy at this time are far outweighed by the negative impacts on PFS specialists.

H.R. 6048, introduced by Congressman Bobby Rush (D-IL) and Congressman Gus Bilirakis (R-FL), would direct the Secretary of Health and Human Services to maintain current clinical labor data in the PFS database and report to Congress on fundamental reform of the PFS. Specialty care providers are urging all the members of Congress to work in a bipartisan fashion to halt the clinical labor cuts for 2022, support H.R. 6048, and work on fundamental reform of the Physician Fee Schedule.

Specialty provider societies and groups in support of H.R. 6048 include:

American College of Radiation Oncology

American Society of Diagnostic and Interventional Nephrology

American Society of Nuclear Cardiology

American Vein & Lymphatic Society

American Venous Forum

Alliance for Physical Therapy Quality and Innovation

Association of Black Cardiologists

CardioVascular Coalition

Dialysis Vascular Access Coalition

The Fibroid Coalition

Outpatient Endovascular and Interventional Society

Preventive Cardiovascular Nurses Association

Renal Physicians Association

Society for Cardiovascular Angiography & Interventions

Society of Interventional Radiology

Society for Vascular Medicine

United Specialists for Patient Access

Share article on social media or email:

ALTAMONTE SPRINGS, Fla. (PRWEB)
December 02, 2021

MedTech Momentum, Inc., a leading medical device marketing agency, welcomes Andy Rock, Francisco Javier Perez, Leonel Dominguez, and Mathieu Charleux as members of its MedTech Marketing Advisory Board. This elite team of multi-faceted MedTech experts will deliver experience-based actionable insights and roadmaps to help companies maximize their growth and value-creation potential.

Guillaume Viallaneix, MedTech Momentum founder and president, stated, “The great majority of our clients come to us with ground-breaking innovations that they want to commercialize successfully in the US, around the world, or both. We know from experience that their marketing strategies can only be successful in the long term if they are knowledge and experience based in all facets of the MedTech business cycle, not just sales and marketing. This is why we have decided to help them by forming our one-of-a-kind MedTech Marketing Advisory Board. It is a privilege to have such formidable experts on the MedTech Momentum team to ensure that all medical device companies looking for the best advice have access to it.”

The board leverages its advisors’ unique reservoir of MedTech experience and knowledge in areas as diverse as:

• 
  Lean business planning & exit strategy
• Financial strategy & fundraising
• Product development & U.S. regulatory affairs
• Global expansion
• International regulatory strategy

Introducing the MedTech Marketing Advisory Board:

Andrew Rock – Lean Business Planning & Exit Strategy

Andy Rock is an accomplished MedTech entrepreneur, inventor, senior executive, investor, public speaker, and advisor to management teams and boards of directors. Known as one of the original co-founders of renowned spinal technology company K2M (i.e., K2M Group Holdings, Inc.), acquired by Stryker for $1.4B in 2018, he spent the last three decades developing a unique set of technological and analytical skills in the medical space. His U.S. and international experience allow him to identify opportunities across multiple health care sectors and help turn them into highly valuable organizations.

In 2003, Andy also co-founded NeuroSpine Ventures to help early-stage MedTech companies develop and execute successful growth and value-creation strategies, leading to successful liquidity events. Since inception, NeuroSpine Ventures has invested in nine startups, achieving six exits with returns on investments ranging from 85% to 3,200%. His broad areas of expertise are a clear competitive advantage that MedTech Momentum clients can tap into for better decision-making.

F. Javier Perez – Financial Strategy & Fundraising

Francisco Javier Perez, CFA, joins the MedTech Momentum Advisory Board with years of extensive experience in health care investment banking, investment management, and financial services. He currently serves as the managing director and chief operating officer for the investment bank Commenda, Inc. as well as the principal for Commenda Securities, LLC. In addition to his roles at Commenda, Javier is a portfolio specialist at Skyview Investment Advisors, where he is actively involved in alternative and venture investments as well as managing investment portfolios on behalf of health care clients.

Javier’s passion is in helping build and fund businesses and teams in the health care innovation space, with the goal of making sure much-needed innovations make it to patients successfully. This is precisely what most MedTech Momentum clients are looking for.

Leonel Dominguez – Product Development & U.S. Regulatory Affairs

As founder and president of Hyperjax Biomedical Technologies, a medical device engineering firm, Leonel Dominguez comes to the MedTech Momentum Advisory Board with 35 years of technical leadership experience in commercial product development engineering, intellectual property, quality, and regulatory affairs, with medical device organizations such as Medtronic-Xomed, Smith & Nephew and Scient’x USA. He has assisted over 50 client companies design, and commercially launch hundreds of medical products in use today.

Over the course of his career, he has developed the technical, analytical, and managerial skills to help companies take medical devices from simple napkin designs to full commercialization. The range of medical technologies Leonel has been involved covers multiple specialties such as orthopedics, spine, trauma, head and neck, extremity, robotic-assisted and micro-endoscopic surgery.

As the market is evolving, Leonel has also developed a unique expertise in technological matters related to rapid prototyping, 3-D printing, and manufacturing. Leonel’s technical expertise represents of valuable source of knowledge that MedTech Momentum’s clients can leverage to their benefit. Mathieu Charleux – Global Expansion & International Regulatory Affairs

Based in France, Mathieu Charleux possesses two decades of experience developing MedTech organizations in Europe and around the world. He specializes in helping MedTech companies of all sizes grow profitably internationally. Mathieu provides MedTech companies with actionable insights, guidance, and tools that enable faster, smarter decisions and stronger performance in all affairs related to business development, international regulatory compliance, and operations.

Mathieu, as a co-founder of MD101, MDxp, and Hirondelle Medical as well as an EMT, is a strategic thinker and entrepreneur who also acts as a key advisor to multiple medical device companies around the world. His track record in building value for medical device start-ups and mid-size companies in an international environment is a major asset available to MedTech Momentum clients.

About MedTech Momentum Founded in 2013, MedTech Momentum is an experienced full-service medical marketing agency headquartered in the greater Orlando, Florida, area. Applying its signature “MT-7 Framework for Growth” formula, the company is 100% focused on helping medical device organizations in the US and internationally execute sustainable and scalable value-driven growth strategies. Armed with a team of renowned strategic advisors and creative personalities, MedTech Momentum possesses a unique vantage point on market dynamics and new technologies in the digital era.

Media Contact

Guillaume Viallaneix

Phone: +1-407-960-2994

Email: guillaume@medtechmomentum.com

Website: https://medtechmomentum.com

“The solution automatically discovers and maps infrastructure dependencies, as well as providing built-in dynamic threshold alerting that supports expedited troubleshooting.”

PHILADELPHIA (PRWEB)
December 02, 2021

Goliath Technologies, a leader in end-user experience monitoring and troubleshooting software for hybrid cloud environments, announced today the release of its groundbreaking Goliath Multi-Cloud Monitor offering.

A cloud-native containerized SaaS offering, Goliath Multi-Cloud Monitor provides a unified view of Amazon Web Services (AWS) EC2 and Workspaces, Microsoft Azure, Citrix Cloud and Google Cloud for monitoring and troubleshooting performance, availability, and end-user experience across cloud environments.

IT administrators now have an easy way to monitor, analyze, troubleshoot and report on complex cloud-based infrastructure from a “single-pane of glass.” This improved visibility enables proactive troubleshooting of the root cause of performance issues across the cloud infrastructure while reducing mean time to resolution, increasing first-time fix rates and improving the end-user experience. An integrated in-depth historical reporting function enables data sharing and supports presentation of SLA metrics and permanent fixes to management.

Goliath Multi-Cloud Monitor requires no installation, minimal set-up, and is designed for ease of use. “The solution automatically discovers and maps infrastructure dependencies, as well as providing built-in dynamic threshold alerting that supports expedited troubleshooting,” notes Ted Rainey, Senior Director of Product Management at Goliath. “Critical data and alerts are displayed via an intelligent and customizable dashboard for easy and rapid identification of when and where problems exist that impact the end-user experience.”

For more information on Goliath Multi-Cloud Monitor or to schedule a demonstration visit goliathtechnologies.com or email us at techinfo@goliathtechnologies.com.

About Goliath Technologies

Goliath Technologies enhances end-user experience by enabling proactive IT. Our end-user experience management, monitoring, and troubleshooting products leverage embedded intelligence and automation to proactively identify events and conditions that cause performance issues and resolve them automatically with self-healing capabilities before end users are impacted. Armed with our portfolio of software solutions, IT Pros can deliver a seamless end-user experience regardless of where workloads, applications, or users are located.

Customers include Universal Health Services, Ascension, CommonSpirit Health, Penn National Insurance, American Airlines, Liberty Mutual, Bell Canada, Xerox, HCL, and others. Learn how we Power Proactive IT at goliathtechnologies.com.

Share article on social media or email: